CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
131 hedge funds and large institutions have $2.15B invested in China Biologic Products Holdings, Inc. in 2016 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less call options, than puts
Call options by funds: $15M | Put options by funds: $18.8M
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
131
Holding in Top 10
6
Calls
$15M
Puts
$18.8M
Top Buyers
| 1 | +$206M | |
| 2 | +$118M | |
| 3 | +$91M | |
| 4 |
HIM
Hermes Investment Management
London Uk,
United Kingdom
|
+$24.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.4M |
Top Sellers
| 1 | -$487M | |
| 2 | -$28.9M | |
| 3 | -$18.2M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$17.7M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$12.7M |